Topics
Cutting-Edge Imaging Devices
July 2007
Carbohydrate Quality, AMD Vision Loss Linked
CONNI BERGMANN KOURY, EDITOR-IN-CHIEF
Ocular Neovascularization: In Vitro and In Vivo Models
The development of these models provides researchers with an important tool for studying the angiogenic process.
JOHN S. PENN, PhD, AND SUSAN E. YANNI
Cataract, AMD are Associated With Increased Mortality
Further studies are needed to clarify whether visual impairment in older people accelerates aging and frailty.
London Project Aims to Cure AMD
Backers hope to develop surgical therapy to stabilize and restore vision.
LEAH D. FARR, ASSOCIATE EDITOR
Handling Increased Patient Flow in a Retina Subspecialty Practice
When things are running as they should, the doctors should never wait for anything. Patients flow to them so that they never have downtime. It makes for an exhausting day for the physicians because they never stop, but it is very efficient.
ALEX STOCKDALE
Amount and Type of Dietary Fat Plays a Role in Vision
Evidence shows high-fat and low-fish diets may increase the risk for ARM.
CÉ,CILE DELCOURT, PhD
IVTA Useful in Uveitic Eyes Having Cataract Extraction
In a pilot study of 19 eyes, the incidence of macular edema was markedly reduced.
NARCISS OKHRAVI, FRCOphth, PhD
Vision Problems Remain an Economic Drain
Preventing vision loss is not only a medical imperative but an economic one as well.
Protein Shows Potential as Treatment for ROP
Promising discovery may prevent eye damage in premature babies.
MARIA B. GRANT, MD
25-gauge Vitrectomy Safe for Macular Surgery
With today's increasingly complete and efficient surgical instruments, the spectrum of conditions that might lend themselves to this minimally invasive approach is growing.
FABIO PATELLI, MD
Early Detection and Better Results for AMD
The Foresee PHP is an important tool for determining the conversion to neovascular AMD.
DIANA REEVES, MD
Clinical Trial Update: AMD
Trial: Genetic Study of Age-Related Macular Degeneration (AMD)
Ocular Angiogenesis as an Organizing Principle in Biomedicine
Jointly sponsored by The Dulaney Foundation and Retina Today Release Date: July 31, 2007. Expiration Date: August 31, 2008. This continuing medical education activity is supported by an educational grant from Genentech.
JUDAH FOLKMAN, MD
5 Questions with Mark Humayun, MD
Dr. Humayun marks his 20th year of involvement in the development of an artificial retina.
Mark Humayun, MD
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program